Michael Brandon Westover, MD
Epileptologists · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 13
- 2 carriers
- Offices
- 2
Offices
2 locations · Stanford Health Care · Harvard Medical Faculty Phys at Beth Israel Deaconess Med Ctr Inc
Looking this up.
Hospitals listed: Beth Israel Deaconess Medical Center. That is not proof they admit you there this week.
Plans that list them
13 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Westover’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
13 of 13 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Beth Israel Deaconess Medical CenterBoston, MAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Beth Israel Lahey Health, which runs 10 hospitalsHome of Dana-Farber/Harvard Cancer Center, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 79% would definitely recommend itOverall rating: 3 of 5 starsWorse than the national rate — Postoperative hemorrhage or hematoma rate: 3.94 (2.98 to 4.91) · 5,770 cases, Jul 2022 – Jun 2024Worse than the national rate — SSI - Abdominal Hysterectomy: 3.752, Oct 2024 – Sep 2025Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 12.8 (11.3 to 14.4) · 1,558 cases, Jan 2024 – Dec 2024Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.55, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.565, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.593, Oct 2024 – Sep 2025
See every measure and the patient survey for Beth Israel Deaconess Medical Center
Behind the star rating — Deaths: 4 better, 4 the same, 0 worse of 8 measures. Safety: 3 better, 4 the same, 1 worse of 8 measures. Readmissions: 0 better, 7 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Postoperative hemorrhage or hematoma rateComplications and deaths | 3.94 (2.98 to 4.91) · 5,770 cases | Worse | Jul 2022 – Jun 2024 |
| SSI - Abdominal HysterectomyInfections | 3.752 | Worse | Oct 2024 – Sep 2025 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.8 (11.3 to 14.4) · 1,558 cases | Worse | Jan 2024 – Dec 2024 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.55 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.565 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.593 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.07 (0.4 to 1.74) · 4,681 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.03 (0.85 to 1.2) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 182.52 (157.03 to 208.01) · 432 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.3 · 342 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.7 · 170 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.3 · 366 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.9 · 964 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 11 · 620 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.3 · 554 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 6,560 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0.04 to 0.33) · 17,760 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.11 to 0.43) · 18,937 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.73 (2.48 to 4.99) · 6,442 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.53 (0.47 to 2.6) · 3,059 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.37 (3.07 to 9.67) · 2,892 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.05 (3.85 to 8.26) · 3,016 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.33 (0.11 to 2.54) · 1,427 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.84 (0.49 to 1.19) · 16,829 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 252 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.884 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.145 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.3 · 629 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.9 · 1,411 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 25.9 · 583 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 30.3 · 1,235 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 7.3 · 673 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.1 · 767 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5 (4.2 to 6.1) · 1,558 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.7 · 245 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.2 · 233 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.1 · 239 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.4 (10.2 to 14.9) · 5,120 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.3) · 1,196 cases | No different | Jan 2024 – Dec 2024 |
What patients said (5,505 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 72% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 64% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 75% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 78% |
| Nurses "always" explained things so they could understand | 78% |
| Nurses "always" listened carefully | 80% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 51% |
| "YES", patients would definitely recommend the hospital | 79% |
| Staff "always" explained possible side effects | 51% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$34,581
Medicare paid this office $34,581 for 135 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional | 68 | $22,177 | $172 |
| Measurement of brain wave activity with video (veeg), 2-12 hours with review and report by health care professional | 43 | $4,569 | $104 |
| Long return visit (40+ min) | 25 | $3,302 | $107 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 13 | $1,948 | $97 |
Who their Medicare patients are
135 Original Medicare patients in 2024. Average age 73 · Under 65 13% · 85 and older 13% · Women 50% · Also on Medicaid 35% · Health risk score 2.12. Above the middle of the specialty; the typical neurology clinician is at 1.61.
Conditions among them: High blood pressure 75% · Stroke 44% · Coronary heart disease 41% · Heart failure 39% · Atrial fibrillation 38% · Dementia 38% · Diabetes 36% · Chronic kidney disease 36% · Depression 30% · Cancer 17% · COPD 16%.
The office billed $138,770, Medicare allowed $44,475 and paid $34,581; for 251 services of 15 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 135 | 251 | 73 | 2.12 | $138,770 | $34,581 |
| 2023 | 154 | 276 | 71 | 2.24 | $152,099 | $37,822 |
| 2022 | 135 | 206 | 69 | 2.06 | $119,880 | $26,159 |
| 2021 | 189 | 290 | 68 | 2.01 | $171,659 | $37,786 |
| 2020 | 207 | 337 | 67 | 2.26 | $200,151 | $42,538 |
| 2019 | 278 | 419 | 66 | 2.38 | $433,164 | $69,852 |
| 2018 | 311 | 494 | 68 | 2.31 | $509,625 | $82,655 |
| 2017 | 319 | 561 | 66 | 2.27 | $638,808 | $97,972 |
| 2016 | 316 | 564 | 66 | 2.32 | $384,999 | $75,102 |
| 2015 | 289 | 488 | 66 | 2.34 | $362,920 | $73,745 |
| 2014 | 258 | 387 | 66 | 2.11 | $243,533 | $57,085 |
| 2013 | 280 | 427 | 66 | 2.17 | $278,954 | $65,293 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 4 services
| Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional | 83 | $22,635 | $171 |
| Measurement of brain wave activity with video (veeg), 2-12 hours with review and report by health care professional | 51 | $5,621 | $106 |
| Long return visit (40+ min) | 22 | $2,796 | $122 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 18 | $2,537 | $79 |
2022: 4 services
| Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional | 34 | $14,174 | $177 |
| Measurement of brain wave activity (eeg), 61-119 minutes | 48 | $3,714 | $74 |
| Long return visit (40+ min) | 24 | $3,705 | $128 |
| Measurement of brain wave activity with video (veeg), 2-12 hours with review and report by health care professional | 12 | $1,741 | $116 |
2021: 5 services
| Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional | 46 | $17,892 | $181 |
| Long return visit (40+ min) | 29 | $7,910 | $149 |
| Measurement of brain wave activity (eeg), 61-119 minutes | 76 | $5,779 | $76 |
| Measurement of brain wave activity with video (veeg), 2-12 hours with review and report by health care professional | 15 | $1,763 | $118 |
| Measurement of brain wave activity (eeg), awake and drowsy | 14 | $708 | $51 |
2020: 7 services
| Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional | 57 | $24,075 | $185 |
| Long return visit (40+ min) | 38 | $6,631 | $114 |
| Measurement of brain wave activity with video (veeg), 2-12 hours with review and report by health care professional | 27 | $3,369 | $120 |
| Measurement of brain wave activity (eeg), awake and drowsy | 43 | $2,228 | $52 |
| Telephone medical discussion with physician, 21-30 minutes | 14 | $1,278 | $85 |
| Measurement of brain wave activity (eeg), 61-119 minutes | 15 | $1,062 | $71 |
| Measurement of brain wave activity (eeg), awake and asleep | 18 | $836 | $46 |
2019: 5 services
| Monitoring and localization of seizure activity over 24-hour period using 16-channel electroencephalograph (EEG) | 91 | $51,003 | $283 |
| Long return visit (40+ min) | 57 | $8,037 | $109 |
| Measurement of brain wave activity (eeg), awake and drowsy | 85 | $4,342 | $50 |
| Measurement of brain wave activity (eeg), awake and asleep | 38 | $1,995 | $51 |
| Return visit (30+ min) | 11 | $1,024 | $79 |
2018: 7 services
| Monitoring and localization of seizure activity over 24-hour period using 16-channel electroencephalograph (EEG) | 80 | $57,485 | $278 |
| Long return visit (40+ min) | 54 | $8,502 | $112 |
| Measurement of brain wave activity (eeg), awake and drowsy | 72 | $3,616 | $50 |
| Measurement of brain wave activity (eeg), awake and asleep | 61 | $3,063 | $50 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 16 | $2,786 | $174 |
| New patient visit (60+ min) | 13 | $2,348 | $181 |
| Return visit (30+ min) | 16 | $1,420 | $89 |
2017: 6 services
| Monitoring and localization of seizure activity over 24-hour period using 16-channel electroencephalograph (EEG) | 114 | $79,112 | $273 |
| Long return visit (40+ min) | 46 | $6,576 | $108 |
| Measurement of brain wave activity (eeg), awake and drowsy | 93 | $4,747 | $48 |
| Measurement of brain wave activity (eeg), awake and asleep | 57 | $2,737 | $48 |
| Return visit (30+ min) | 19 | $1,628 | $81 |
| Measurement of brain wave activity (eeg), 41-60 minutes | 14 | $663 | $47 |
2016: 8 services
| Monitoring and localization of seizure activity over 24-hour period using 16-channel electroencephalograph (EEG) | 65 | $40,121 | $267 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 49 | $8,284 | $162 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 34 | $8,215 | $85 |
| Long return visit (40+ min) | 36 | $4,463 | $99 |
| Measurement of brain wave activity (eeg), awake and drowsy | 86 | $4,242 | $48 |
| Return visit (30+ min) | 25 | $2,130 | $79 |
| Measurement of brain wave activity (eeg), awake and asleep | 42 | $2,024 | $48 |
| Measurement of brain wave activity (eeg), 61-119 minutes | 24 | $1,955 | $75 |
2015: 7 services
| Monitoring and localization of seizure activity over 24-hour period using 16-channel electroencephalograph (EEG) | 95 | $44,100 | $267 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 49 | $7,931 | $162 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 27 | $6,376 | $85 |
| Long return visit (40+ min) | 56 | $5,794 | $92 |
| Measurement of brain wave activity (eeg), awake and drowsy | 61 | $2,941 | $46 |
| Measurement of brain wave activity (eeg), 61-119 minutes | 15 | $1,146 | $76 |
| Measurement of brain wave activity (eeg), awake and asleep | 19 | $952 | $48 |
2014: 5 services
| Monitoring and localization of seizure activity over 24-hour period using 16-channel electroencephalograph (EEG) | 61 | $37,063 | $271 |
| Long return visit (40+ min) | 60 | $8,061 | $106 |
| Measurement of brain wave activity (eeg), awake and drowsy | 73 | $3,555 | $48 |
| Return visit (30+ min) | 18 | $1,738 | $87 |
| Measurement of brain wave activity (eeg), awake and asleep | 35 | $1,618 | $46 |
2013: 7 services
| Monitoring and localization of seizure activity over 24-hour period using 16-channel electroencephalograph (EEG) | 74 | $41,261 | $263 |
| Long return visit (40+ min) | 51 | $7,103 | $109 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 32 | $5,174 | $162 |
| Measurement of brain wave activity (eeg), awake and drowsy | 58 | $2,705 | $46 |
| New patient visit (60+ min) | 13 | $2,222 | $171 |
| Measurement of brain wave activity (eeg), awake and asleep | 40 | $1,904 | $46 |
| Measurement of brain wave activity (eeg), 61-119 minutes | 12 | $963 | $74 |
Medicaid work
$1,355 in 2024
Medicaid paid $1,355 for 19 billed services this clinician did in 2024, up to 14 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Electroencephalogram (EEG), continuous recording, physician or other qualified health care professional review of recorded events, analysis of spike and seizure detection, each increment of greater than 12 hours, up to 26 hours of EEG recording, interpretation and report after each 24-hour period; with video (VEEG) | 19 | $1,355 |
| 2024 | 19 | 1 | 14 | $1,355 |
| 2023 | 38 | 1 | 19 | $2,287 |
| 2021 | 51 | 2 | 19 | $3,061 |
| 2019 | 74 | 1 | 13 | $9,539 |
| 2018 | 36 | 2 | 15 | $4,507 |
See the largest Medicaid services in earlier years
2023
| Electroencephalogram (EEG), continuous recording, physician or other qualified health care professional review of recorded events, analysis of spike and seizure detection, each increment of greater than 12 hours, up to 26 hours of EEG recording, interpretation and report after each 24-hour period; with video (VEEG) | 38 | $2,287 |
2021
| Electroencephalogram (EEG), continuous recording, physician or other qualified health care professional review of recorded events, analysis of spike and seizure detection, each increment of greater than 12 hours, up to 26 hours of EEG recording, interpretation and report after each 24-hour period; with video (VEEG) | 18 | $1,656 |
| Electroencephalogram (EEG) extended monitoring; 61-119 minutes | 33 | $1,405 |
2019
| Monitoring for localization of cerebral seizure focus by cable or radio, 16 or more channel telemetry, combined electroencephalographic (EEG) and video recording and interpretation (eg, for presurgical localization), each 24 hours | 74 | $9,539 |
2018
| Monitoring for localization of cerebral seizure focus by cable or radio, 16 or more channel telemetry, combined electroencephalographic (EEG) and video recording and interpretation (eg, for presurgical localization), each 24 hours | 21 | $3,682 |
| Long return visit (40+ min) | 15 | $825 |
Drugs they prescribed that Part D paid
$238,257
Pharmacies billed $238,257 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 464) in 2024. At or below the middle of the specialty; the typical neurology clinician is at 0%.
371 generic and 72 brand-name prescriptions · $238,257 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Banzel | 19 | $120,809 | $6,358 |
| Epidiolex | 11 | $38,609 | $3,510 |
| Aptiom | 26 | $32,142 | $1,236 |
| Clobazam | 45 | $3,356 | $75 |
| Levetiracetam | 72 | $2,139 | $30 |
See all 15 drugs
| Banzel | 19 | $120,809 | $6,358 |
| Epidiolex | 11 | $38,609 | $3,510 |
| Aptiom | 26 | $32,142 | $1,236 |
| Clobazam | 45 | $3,356 | $75 |
| Levetiracetam | 72 | $2,139 | $30 |
| Levetiracetam Er | 18 | $1,441 | $80 |
| Zonisamide | 24 | $998 | $42 |
| Lamotrigine | 32 | $916 | $29 |
| Phenobarbital | 21 | $889 | $42 |
| Lacosamide | 23 | $873 | $38 |
| Divalproex | 19 | $545 | $29 |
| Topiramate | 20 | $411 | $21 |
| Clonazepam | 20 | $225 | $11 |
| Paroxetine | 13 | $82 | $6 |
| Lorazepam | 19 | $81 | $4 |
Year by year
| 2024 | 464 | 44 | 0% (0) | 16% | $238,257 |
| 2023 | 161 | 41 | 0% (0) | None | $57,831 |
| 2022 | 350 | 43 | 0% (0) | 18% | $206,099 |
| 2021 | 461 | 47 | 0% (0) | 27% | $270,222 |
| 2020 | 435 | 46 | 0% (0) | 24% | $172,873 |
| 2019 | 432 | 51 | 0% (0) | 23% | $198,813 |
| 2018 | 317 | 37 | 0% (0) | 20% | $138,539 |
| 2017 | 296 | 29 | 0% (0) | 18% | $110,874 |
| 2016 | 327 | 25 | 0% (0) | 12% | $66,734 |
| 2015 | 307 | 29 | 0% (0) | 16% | $74,074 |
| 2014 | 431 | 34 | 0% (0) | 23% | $69,821 |
| 2013 | 462 | 29 | 0% (0) | 17% | $68,710 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 4 drugs
| Clobazam | 22 | $2,856 | $130 |
| Levetiracetam | 35 | $1,637 | $47 |
| Topiramate | 11 | $363 | $33 |
| Lorazepam | 11 | $86 | $8 |
2022: 13 drugs
| Lamictal Xr | 15 | $49,128 | $3,275 |
| Lamotrigine Er | 15 | $34,621 | $2,308 |
| Vimpat | 24 | $27,296 | $1,137 |
| Clobazam | 40 | $23,184 | $580 |
| Oxtellar Xr | 12 | $15,751 | $1,313 |
| Dilantin | 12 | $8,036 | $670 |
| Lacosamide | 22 | $7,535 | $342 |
| Levetiracetam | 61 | $3,532 | $58 |
| Lamotrigine | 48 | $1,324 | $28 |
| Oxcarbazepine | 13 | $1,158 | $89 |
| Topiramate | 15 | $417 | $28 |
| Clonazepam | 21 | $370 | $18 |
| Phenytoin Sodium Extended | 12 | $340 | $28 |
2021: 12 drugs
| Vimpat | 77 | $91,350 | $1,186 |
| Lamictal Xr | 15 | $69,965 | $4,664 |
| Lamotrigine Er | 18 | $29,881 | $1,660 |
| Oxtellar Xr | 12 | $14,584 | $1,215 |
| Clobazam | 41 | $7,242 | $177 |
| Levetiracetam | 73 | $6,894 | $94 |
| Oxcarbazepine | 18 | $1,567 | $87 |
| Lamotrigine | 61 | $1,347 | $22 |
| Zonisamide | 12 | $753 | $63 |
| Phenytoin Sodium Extended | 13 | $634 | $49 |
| Clonazepam | 34 | $628 | $18 |
| Topiramate | 17 | $604 | $36 |
2020: 10 drugs
| Vimpat | 71 | $66,305 | $934 |
| Lamictal Xr | 17 | $50,816 | $2,989 |
| Oxtellar Xr | 11 | $12,612 | $1,147 |
| Levetiracetam | 87 | $6,213 | $71 |
| Clobazam | 35 | $5,336 | $152 |
| Lamotrigine | 59 | $1,240 | $21 |
| Clonazepam | 52 | $882 | $17 |
| Phenytoin Sodium Extended | 18 | $788 | $44 |
| Topiramate | 21 | $748 | $36 |
| Lorazepam | 13 | $61 | $5 |
2019: 12 drugs
| Vimpat | 57 | $57,616 | $1,011 |
| Lamictal Xr | 12 | $51,985 | $4,332 |
| Lamotrigine Er | 21 | $32,821 | $1,563 |
| Clobazam | 21 | $11,327 | $539 |
| Levetiracetam | 82 | $4,949 | $60 |
| Levetiracetam Er | 15 | $1,682 | $112 |
| Topiramate | 25 | $1,349 | $54 |
| Lamotrigine | 43 | $1,144 | $27 |
| Clonazepam | 39 | $991 | $25 |
| Zonisamide | 17 | $706 | $42 |
| Phenytoin Sodium Extended | 16 | $425 | $27 |
| Lorazepam | 17 | $103 | $6 |
2018: 11 drugs
| Lamictal Xr | 18 | $66,802 | $3,711 |
| Lamotrigine Er | 21 | $21,786 | $1,037 |
| Vimpat | 17 | $18,836 | $1,108 |
| Oxtellar Xr | 15 | $11,716 | $781 |
| Levetiracetam | 52 | $2,082 | $40 |
| Levetiracetam Er | 12 | $1,303 | $109 |
| Lamotrigine | 44 | $818 | $19 |
| Clonazepam | 48 | $647 | $13 |
| Phenytoin Sodium Extended | 17 | $506 | $30 |
| Gabapentin | 14 | $279 | $20 |
| Lorazepam | 15 | $35 | $2 |
2017: 9 drugs
| Lamictal Xr | 15 | $47,170 | $3,145 |
| Lamotrigine Er | 24 | $24,777 | $1,032 |
| Oxtellar Xr | 24 | $14,133 | $589 |
| Levetiracetam | 82 | $4,210 | $51 |
| Levetiracetam Er | 14 | $1,429 | $102 |
| Phenytoin Sodium Extended | 22 | $724 | $33 |
| Lamotrigine | 27 | $417 | $15 |
| Topiramate | 21 | $402 | $19 |
| Clonazepam | 30 | $135 | $5 |
2016: 10 drugs
| Oxtellar Xr | 23 | $11,710 | $509 |
| Levetiracetam | 89 | $4,260 | $48 |
| Levetiracetam Er | 28 | $3,090 | $110 |
| Lamotrigine | 70 | $858 | $12 |
| Dilantin | 12 | $847 | $71 |
| Phenytoin Sodium Extended | 17 | $534 | $31 |
| Topiramate | 16 | $452 | $28 |
| Dilantin | 12 | $295 | $25 |
| Clonazepam | 22 | $79 | $4 |
| Lorazepam | 11 | $30 | $3 |
2015: 8 drugs
| Lamotrigine Er | 11 | $17,488 | $1,590 |
| Oxtellar Xr | 17 | $9,378 | $552 |
| Levetiracetam | 69 | $4,133 | $60 |
| Levetiracetam Er | 19 | $2,548 | $134 |
| Phenytoin Sodium Extended | 13 | $785 | $60 |
| Lamotrigine | 55 | $580 | $11 |
| Topiramate | 19 | $182 | $10 |
| Clonazepam | 15 | $68 | $5 |
2014: 11 drugs
| Vimpat | 29 | $20,011 | $690 |
| Lamictal Xr | 12 | $10,337 | $861 |
| Levetiracetam | 67 | $8,444 | $126 |
| Depakote Er | 17 | $2,984 | $176 |
| Lamotrigine | 87 | $1,694 | $19 |
| Oxcarbazepine | 32 | $1,071 | $33 |
| Carbamazepine | 26 | $673 | $26 |
| Divalproex | 12 | $533 | $44 |
| Topiramate | 23 | $225 | $10 |
| Clonazepam | 24 | $106 | $4 |
| Lorazepam | 16 | $44 | $3 |
2013: 15 drugs
| Levetiracetam | 81 | $12,838 | $158 |
| Keppra Xr | 12 | $12,384 | $1,032 |
| Depakote | 12 | $9,618 | $801 |
| Lamictal Xr | 11 | $9,505 | $864 |
| Vimpat | 13 | $7,968 | $613 |
| Tegretol Xr | 13 | $4,268 | $328 |
| Oxcarbazepine | 32 | $2,504 | $78 |
| Tegretol | 12 | $1,948 | $162 |
| Lamotrigine | 72 | $1,736 | $24 |
| Gabapentin | 20 | $1,735 | $87 |
| Divalproex | 12 | $642 | $54 |
| Carbamazepine | 37 | $467 | $13 |
| Topiramate | 32 | $433 | $14 |
| Lorazepam | 45 | $320 | $7 |
| Clonazepam | 21 | $123 | $6 |
Money from drug and device companies
$61 in 2025
| 2025 | 1 | 2 | None | $61 |
| 2023 | 1 | 1 | None | $76 |
| 2022 | 2 | 2 | None | $119 |
| 2019 | 2 | 2 | $2,250 | $2,280 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Jazz Pharmaceuticals | Epidiolex | $61 | 2 payments
|
See all 2 published payments
| Jazz Pharmaceuticals | Meals · 2025-12-06 | Epidiolex | $35 |
| Jazz Pharmaceuticals | Meals · 2025-11-04 | Epidiolex | $26 |
See earlier years (2023, 2022, 2019)
2023: $76
| Ucb | None | $76 | 1 payment
|
2022: $119
| Neurelis | Valtoco | $83 | 1 payment
|
| LivaNova USA | Vns Therapy Sentiva Model 1000 Generator | $35 | 1 payment
|
2019: $2,280
| Celgene | None | $2,250 | 1 payment
|
| Ucb | Briviact | $30 | 1 payment
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| Takeda Pharmaceuticals U.S.A., Inc. · Takeda Bidmc Research Collaboration for Narcolepsy Ehr Phenotyping Algorithm · 2025 | Their institution | $297,500 |
| Takeda Pharmaceuticals U.S.A., Inc. · Con-24037843-1 Bidmc Research Collaboration Agreement Narcolepsy Algorithm Development · 2025 | Their institution | $297,500 |
| Ceribell, Inc. · Ceribell Decide · 2019 | Their institution | $47,094 |
Professional record
- NPI
- 1184653487
- Licence
- MA 237703
- Trained
- Washington University School of Medicine, 2006
- Group
- Stanford Health Care · Harvard Medical Faculty Phys at Beth Israel Deaconess Med Ctr Inc
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 2084E0001X (2084E0001X); Neurology (2084N0400X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2006-07-01
- NPI last updated
- 2026-03-20
- NPI record certified
- 2026-03-20
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 55 Fruit St, Boston, MA, 02114